FDA Digital Twin Submission Package Outline (ICH Q5C/Q9 Annex)

The FDA Digital Twin Submission Package Outline is an evolving conceptual resource—not a binding regulation—that harmonizes digital process simulation with established ICH quality frameworks. It emphasizes traceability from physical process understanding to virtual representation, requiring rigorous model qualification, uncertainty quantification, and alignment with control strategy elements defined in ICH Q5C (e.g., stability-indicating parameters) and ICH Q9 (e.g., risk identification, mitigation, and monitoring). Central to the outline is the requirement that digital twins be embedded within a Quality Risk Management (QRM) lifecycle: models must be justified by risk assessments, validated against experimental data across relevant design spaces, and accompanied by documented model limitations and sensitivity analyses. Applications span real-time release testing, continuous manufacturing process verification, and post-approval change management—where digital twins serve as dynamic surrogates for empirical experimentation. The outline further mandates transparency in model architecture (e.g., mechanistic vs. hybrid vs. ML-based), data provenance (including raw sensor streams and metadata), and version-controlled documentation aligned with 21 CFR Part 11 and ICH M4Q(R2) electronic submission standards.